鍎跨浣庣骇鍒兌璐ㄧ槫锛坧LGG锛夋偅鑰呮槸鎸囦綆绾у埆鑴戣兌璐ㄧ槫涓殑骞撮緞锛18宀佺殑鍎跨鍜岄潚灏戝勾鎮ｈ€咃紝涓旀墍鎮ｇ柧鐥呬负2021骞翠笘鐣屽崼鐢熺粍缁囷紙WHO锛変腑鏋㈢缁忕郴缁熻偪鐦ゅ垎绫讳腑鎵€鐗规寚鐨勫寘鎷効绔ュ瀷寮ユ极鎬т綆绾у埆鑳惰川鐦ゃ€佸眬闄愭€ф槦褰㈢粏鑳炶兌璐ㄧ槫绛夊湪鍐呯柧鐥呰€銆俻LGG鏄効绔ユ渶甯歌鐨勪腑鏋㈢缁忕郴缁熻偪鐦锛屽崰鎵€鏈夊効绔ヤ腑鏋㈢缁忕郴缁熻偪鐦ょ殑40-50%銆2015骞寸編鍥芥柊璇婃柇鐨刾LGG鐥呬緥鏁扮害涓1000~1600渚锛屽湪涓浗灏氭棤鏄庣‘鐨勫効绔ヤ綆绾у埆鑳惰川鐦ゅ彂鐥呯巼鎶ラ亾銆

鏍规嵁涓€椤瑰涓績銆佸崟鑷傗叀鏈熶复搴婄爺绌舵暟鎹樉绀^[1]锛屽杩堝畞^?娌荤枟BRAF铻嶅悎绐佸彉鎴朆RAF V600E绐佸彉鎴朜F1绐佸彉闃虫€х殑鍎跨浣庣骇鍒剳鑳惰川鐦ゆ偅鑰呯殑瀹㈣缂撹В鐜囷紙ORR锛夎揪鍒颁簡68.2%锛岀柧鐥呮帶鍒剁巼锛圖CR锛夊彲杈100%锛屽湪鐮旂┒鏈熼棿鏃犳偅鑰呭嚭鐜扮柧鐥呰繘灞锛屾墍鏈夋偅鑰呭潎涓嶅悓绋嬪害鑾风泭銆傛涓村簥鐮旂┒缁撴灉鏄剧ず澶嶈繄瀹^?瀵逛簬BRAF铻嶅悎绐佸彉鎴朆RAF V600E绐佸彉鎴朜F1绐佸彉闃虫€х殑鍎跨浣庣骇鍒兌璐ㄧ槫鍏锋湁鑹ソ鐨勬不鐤楁晥鏋锛屽浜庡効绔ヤ綆绾у埆鑳惰川鐦ょ殑娌荤枟鎻愪緵浜嗛澏鍚戞不鐤楃殑閫夋嫨銆傚杩堝畞^?鏈夋湜鏀瑰彉pLGG鐨勭幇鏈夋不鐤楁牸灞€锛岃鏇村鎮ｈ€呰幏鐩銆

鎴嚦鐩墠锛屽杩堝畞^?宸蹭簬涓浗澧冨唴涓婂競骞惰幏鎵逛袱椤归€傚簲鐥锛屽寘鎷敤浜庢不鐤楁湕鏍兼眽鏂粏鑳炵粍缁囩粏鑳炲鐢熺棁锛圠CH锛夊拰缁勭粐缁嗚優鑲跨槫鎴愪汉鎮ｈ€咃紱浠ュ強2宀佸強2宀佷互涓婁即鏈夌棁鐘銆佹棤娉曟墜鏈殑涓涚姸绁炵粡绾ょ淮鐦わ紙PN锛夌殑鈪犲瀷绁炵粡绾ょ淮鐦銆傗垷F1锛夊効绔ュ強闈掑皯骞存偅鑰銆

澶嶈繄瀹^?鐢ㄤ簬娌荤枟鎴愪汉鈪犲瀷绁炵粡绾ょ淮鐦ょ梾銆佸効绔ヤ綆绾у埆鑴戣兌璐ㄧ槫浜庝腑鍥藉鍐呭潎澶勪簬鈪㈡湡涓村簥璇曢獙闃舵锛岃鑽搧鐢ㄤ簬娌荤枟棰呭鍔ㄩ潤鑴夌暩褰銆佸効绔ユ湕鏍兼眽鏂粏鑳炵粍缁囩粏鑳炲鐢熺棁浜庝腑鍥藉鍐呭潎澶勪簬鈪℃湡涓村簥璇曢獙闃舵銆傚叾涓锛岃鑽搧鐢ㄤ簬鏃犳硶鎵嬫湳鎴栨湳鍚庢畫鐣/澶嶅彂鐨凬F1鐩稿叧鐨勪笡鐘剁缁忕氦缁寸槫鎴愪汉鎮ｈ€銆佸効绔ユ湕鏍兼眽鏂粍缁囩粏鑳炲鐢熺棁涓ら」閫傚簲鐥囧潎宸茶鍥藉鑽搧鐩戠潱绠＄悊灞€鑽搧瀹¤瘎涓績绾冲叆绐佺牬鎬ф不鐤楄嵂鐗╃▼搴銆

[1] 1.Wenbin Li, Ying Mao, Zhuang Kang, et al. A phase II study to explore the efficacy and safety of FCN-159 in recurrent or progressive pediatric low-grade glioma (pLGG) with MAPK pathway activation. ESMO LBA 2023.